The FDA approved the changes to the Harvoni (ledipasvir/sofosbuvir, Gilead Sciences) fixed- dose and Sovaldi (sofosbuvir) labels to update the Warnings and Precautions, Adverse Reactions and Drug Interactions sections, after nine serious cases of symptomatic bradycardia and one fatal cardiac arrest were reported among patients taking amiodarone and Harvoni or amiodarone and sofosbuvir in combination with another direct-acting antiviral (DAA), according to the release. Read more: bit.ly/1HsHHuy
FDA warns of cardiac reactions with H... - HFI Connect - Hep...
FDA warns of cardiac reactions with Harvoni, Sovaldi drug combinations
Written by
mwright
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Just found out I have Hep B and have red spots all over is that normal.
Hello everyone, I recently went to the doctors for food poisoning and found out I have typhiod and...
Overwhelmed
Hi everyone, I'm new to this site and really just looking for somewhere I can talk to people that...
Hepatitis E
I got infected by Hepatitis E two months ago and i am still suffering from this. My highest...
